DRAP allows import, manufacturing of Remdesivir

Shares
DRAP allows import, manufacturing of Remdesivir

ISLAMABAD-Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of Remdesivir used for critically ill patients of COVID-19.

According to spokesman Ministry of National Health Services, on increasing demand, approvals are issued to two importers and 14 local manufacturers.

He said Remdesivir is approved for emergency use in a special emergency meeting in order to ensure early availability.